Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JMP Securities Reiterates Market Outperform on Spectrum Pharmaceuticals, Maintains $4 Price Target

JMP Securities analyst Reni Benjamin reiterates Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Market Outperform and maintains $4 price target.
byBenzinga Newsdesk
February 1, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JMP Securities analyst Reni Benjamin reiterates Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Market Outperform and maintains $4 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts